Investigator-Initiated Research
Helping scientists investigate the unanswered
We will consider providing financial support and/or product supply for novel research proposals that answer important scientific and medical questions in our areas of interest. Grant recipients have the right to publish the results of the study and maintain full control over the research project objectives, design, conduct, data analysis, and interpretation.
Contact us with any questions about requirements and procedures.
Submit a request for grant support.
Areas of interest
Amikacin Liposome Inhalation Suspension and Pulmonary Infections
- NTM pulmonary disease in different populations [such as autoimmune disease/COPD comorbidities and other populations]
- Biomarkers and/or imaging findings for NTM diagnosis, comorbidities, disease progression, and treatment decisions
- Studies in populations with both comorbidities of MACLD and bronchiectasis *
- Adverse event/medication adherence management
- Evaluation of factors affecting patient initiation and acceptance of NTM treatment
- Explore an AI-guided approach to diagnosis and disease management using imaging and other tools
*Any studies noted requiring brensocatib will be considered but held in regions until approved by the relevant health authority.
Bronchiectasis and Other Neutrophil-Related Disorders
Disease State/Mechanism of Disease
- Epidemiology, natural history, clinical course, and progression of bronchiectasis
- Neutrophil serine protease (NSP) biomarkers of disease severity/burden in patients with autoimmune or inflammatory diseases
- Pre-clinical models of neutrophilic inflammation including the effect of DPP1 inhibition on outcomes and potential new biomarkers primarily with a focus on bronchiectasis
Your Privacy Choices